As a patient at Memorial Sloan Kettering, your child, teen, or young adult may be able to take part in a clinical trial, also known as a clinical research study. In a clinical trial, doctors evaluate a new therapy or a therapy combination to find out whether it is more effective than current rhabdomyosarcoma treatments. Nearly every cancer treatment used today exists because of a clinical trial. For every trial, the goal is the same: to provide long-term, disease-free survival.
Our patients have access to many of the latest clinical trials, some of which are available only at MSK. We also take part in many nationwide clinical trials as a founding member of the Children’s Oncology Group, as the coordinating center and co-founder of the Pediatric Oncology Experimental Therapeutics Investigators’ Consortium, and through other trial networks across the United States.
For patients with intermediate- and high-risk rhabdomyosarcoma, we conducted a clinical trial that showed how well the chemotherapy drug combination of irinotecan and carboplatin worked in newly diagnosed patients, both alone and with radiation therapy.
The decision to have your child take part in a clinical trial is entirely up to you and your child. Regardless of whether your child gets standard treatment or therapy through a clinical trial, he or she will benefit from MSK’s ongoing commitment to excellence in patient care.
Learn more about our current clinical trials for rhabdomyosarcoma.